ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

March 26, 1993

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011

Bill To Teach Breast Self-Exam To Teens Wins Political Support; Experts Fear Harm

April 10, 2009